American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Levine
    Levine
  3. Abdel-Wahab
    Abdel-Wahab
  4. Perales
    Perales
  5. Zelenetz
    Zelenetz
  6. Devlin
    Devlin
  7. Horwitz
    Horwitz
  8. Landau
    Landau
  9. Moskowitz
    Moskowitz
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Center for Hematologic Malignancies (176)
  2. Department of Medicine (173)
  3. Hematologic Malignancies, Division of (166)
  4. GSK Faculty (76)
  5. Adult Leukemia (67)
  6. Bone Marrow Transplant (49)
  7. Executive Committee, Center for Hematologic Malignancies (49)
  8. Sloan Kettering Institute Postdocs (46)
  9. Human Oncology and Pathogenesis Program (44)
  10. Hematologic Malignancies Research (42)
Search Within
  1. "2016"
Formats
  1. Meeting Abstract (182)
  2. Journal Article (31)
Groups
  1. Center for Hematologic Malignancies (176)
  2. Department of Medicine (173)
  3. Hematologic Malignancies, Division of (166)
  4. GSK Faculty (76)
  5. Adult Leukemia (67)
  6. Bone Marrow Transplant (49)

More Groups

People
  1. Martin Tallman (29)
  2. Sergio Giralt (22)
  3. Ross Levine (19)
  4. Andrew Zelenetz (15)
  5. Miguel-Angel Perales (15)
  6. Omar Abdel-Wahab (15)

More People

Years
  1. 2016 (213)
Publications
  1. Blood (210)
  2. Hematology-American Society of Hematology Education Program (2)
  3. Blood Advances (1)

Results (213)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia
    Meeting Abstract

    Gadalla, S. M.; Wang, T.; Loftus, D.; Friedman, L.; Dagnall, C.; Haagenson, M. D.; Spellman, S. R.; Buturovic, L.; Blauwkamp, M.; Shelton, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: Results from the expansion cohort of a phase 1/2 study
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Multicolor flow cytometry and multi-gene next generation sequencing are complimentary and highly predictive for relapse in acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Devlin, S.; Maloy, M. A.; Mohanty, A.; Arcila, M.; Tallman, M. S.; Levine, R. L.; Giralt, S. A.; Roshal, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Pembrolizumab, a PD-1 inhibitor, in patients with myelodysplastic syndrome (MDS) after failure of hypomethylating agent treatment
    Meeting Abstract

    Garcia-Manero, G.; Tallman, M. S.; Martinelli, G.; Ribrag, V.; Yang, H.; Balakumaran, A.; Chlosta, S.; Zhang, Y.; Smith, B. D.
    Blood (2016)

    Fulltext@MSK | Save
  • Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses
    Meeting Abstract

    Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Cooperative gene repression by DNA methylation and LSD1-mediated enhancer inactivation in acute myeloid leukemia
    Meeting Abstract

    Duy, C.; Teater, M.; Garrett-Bakelman, F. E.; Lee, T. C.; Meydan, C.; Glass, J. L.; Li, M.; Mohammad, H.; Smitheman, K.; Shih, A. H.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • AICDA introduces epigenetic plasticity in germinal center-derived lymphomas and accelerates lymphomagenesis
    Meeting Abstract

    Dominguez, M. D.; Teater, M.; Redmond, D.; Cheng, Z.; Chaudhuri, J.; Elemento, O.; Melnick, A.; Shaknovich, R.
    Blood (2016)

    Fulltext@MSK | Save
  • Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia (AML)
    Meeting Abstract

    Fathi, A. T.; Erba, H. P.; Lancet, J. E.; Stein, E. M.; Ravandi, F.; Faderl, S.; Walter, R. B.; Advani, A.; DeAngelo, D. J.; Kovacsovics, T. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Importance of achieving complete remission (CR) after intensive therapy for acute myeloid leukemia (AML) in older adults age >= 60 years: Analysis of risk factors for early mortality and re-induction, and impact of quality of response on overall survival (OS) in the ECOG-ACRIN E2906 randomized trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D. A.; Zhang, Y.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save